Taiwan FDA registration a184cef6b32cc73cd3e65813f6bb3a94
"Aeon"Blood Cell Separation Kit
TW: "亞恩"血球細胞分離組
Taiwan·Risk Class 2·MD·AEON BIOTHERAPEUTICS CORP.·Registered Jan 30, 2018 – Jan 30, 2023ExpiredRegistration details
- Analysis ID
- a184cef6b32cc73cd3e65813f6bb3a94
- License Form
- Ministry of Health Medical Device Manufacturing No. 005816
Company information
- Manufacturer
- AEON BIOTHERAPEUTICS CORP.
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- AEON BIOTHERAPEUTICS CORP.
Product details
- Intended Use
- This product can be taken by the patient and separated into red blood cells, white blood cells, plasma and platelets, etc., retaining platelet-rich plasma (PRP).
- Product Type (Level 1)
- B Hematology and pathology devices
- Product Type (Level 2)
- B9245 Automatic Hematology Cell Separator
- Import Information
- Produced in Taiwan, China
Dates and status
- Registration Date
- Jan 30, 2018
- Expiry Date
- Jan 30, 2023
About this record
Access comprehensive regulatory information for "Aeon"Blood Cell Separation Kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number a184cef6b32cc73cd3e65813f6bb3a94 and manufactured by AEON BIOTHERAPEUTICS CORP.. The authorized representative in Taiwan is AEON BIOTHERAPEUTICS CORP..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices